Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64.65 AUD | +1.17% | +2.42% | +6.44% |
12:00pm | Bernstein Adjusts Price Target on Newmont to $45 From $46, Keeps Market Perform Rating | MT |
May. 10 | BNP Paribas Exane Adjusts Price Target on Newmont to $52 From $49 | MT |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's high margin levels account for strong profits.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Sales forecast by analysts have been recently revised upwards.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- With an enterprise value anticipated at 3.22 times the sales for the current fiscal year, the company turns out to be overvalued.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Gold
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+6.44% | 49.81B | - | ||
+25.45% | 34.44B | B | ||
-0.42% | 30.61B | B+ | ||
+16.37% | 25.36B | B | ||
+9.45% | 11.23B | B | ||
+31.78% | 10.36B | B- | ||
+33.04% | 9.66B | A- | ||
-.--% | 8.7B | - | B- | |
+7.18% | 8.58B | B- | ||
+24.35% | 6.42B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- NEM Stock
- NEM Stock
- Ratings Newmont Corporation